semaglutide and intermittent fasting benefits for weight wellness Frontiers | Intermittent fasting in

doi:10.1080/14656566.2024.2436595 Mikdachi H, Dunsmoor-Su R

This medication works the same way, but instead of a shot, you place a small pill under your tongue each day

Orforglipron is the worlds second oral GLP-1 pill for weight management, approved by the FDA in April 2026

Acknowledgements CL is supported by the PON Ricerca e Innovazione-Istruzione e ricerca per il recupero-REACT-EU fundsfromtheItalian Ministry of University and Research

Trial Metric Retatrutide 12mg (TRIUMPH-4) Semaglutide 2.4mg (STEP 1) Mean Weight Loss 28.7% at 68 weeks 14.9% at 68 weeks Mechanism Triple agonist (GLP-1/GIP/GCGR) Single agonist (GLP-1) FDA Status Phase 3 (investigational) Approved (Wegovy) Dosing Weekly subcutaneous Weekly subcutaneous Common Adverse Events GI (nausea, vomiting, diarrhea), dysesthesia GI (nausea, vomiting, diarrhea) Important caveat: These results come from different trial populations and study designs

Records showing vision loss or problems began after starting Ozempic